XBI returns by year
SPDR S&P Biotech ETF has returned +11.6% annually (CAGR) since 2007. Calendar-year, monthly and weekly total returns for SPDR S&P Biotech ETF (XBI) below, through August 18, 2026 — the most recent year is year-to-date.
SPDR S&P Biotech ETF returns by year (2007–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $121.93 | $158.43 | +0.0% | +29.9% | |
| 2025 | $90.06 | $121.93 | +0.5% | +35.9% | |
| 2024 | $89.29 | $90.06 | +0.1% | +1.0% | |
| 2023 | $83.00 | $89.29 | +0.0% | +7.6% | |
| 2022 | $111.96 | $83.00 | +0.0% | -25.9% | |
| 2021 | $140.78 | $111.96 | +0.0% | -20.4% | |
| 2020 | $95.11 | $140.78 | +0.3% | +48.3% | |
| 2019 | $71.75 | $95.11 | +0.0% | +32.6% | |
| 2018 | $84.87 | $71.75 | +0.2% | -15.3% | |
| 2017 | $59.19 | $84.87 | +0.4% | +43.8% | |
| 2016 | $70.20 | $59.19 | +0.2% | -15.4% | |
| 2015 | $62.15 | $70.20 | +0.6% | +13.6% | |
| 2014 | $43.40 | $62.15 | +1.8% | +45.0% | |
| 2013 | $29.30 | $43.40 | +0.3% | +48.4% | |
| 2012 | $22.13 | $29.30 | +0.3% | +32.7% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from XBI's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is SPDR S&P Biotech ETF's average annual return?
- Since 2007, SPDR S&P Biotech ETF (XBI) has returned about 11.6% a year (the compound annual growth rate) and an average calendar-year return of 14.5%.
- What were SPDR S&P Biotech ETF's best and worst years?
- Over 2007–2026, the best year was 2013 (+48.4%) and the worst was 2022 (-25.9%).
- How often is SPDR S&P Biotech ETF up in a year?
- 14 of the 19 full years since 2007 were positive — about 74% of the time.